Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 15,622 results for: pET

Clear keywords
Showing: 4561 - 4580 of 15622 results

  3. pCIOX

    Plasmid
    #51300
    Purpose
    E.coli expression vector for His8-SUMO tagged recombinant protein
    Depositor
    Andrea Mattevi
    Type
    Empty backbone
    Tags
    His8 + SUMO
    Expression
    Bacterial
    Promoter
    T7
    Available Since
    Feb. 28, 2014
    Availability
    Academic Institutions and Nonprofits only
    51300-plasmid-map-sequence-id-78111

    Enlarge

  5. p028g13-Gb1

    Plasmid
    #249632
    Purpose
    Clone 8xHis-residues in tandem with Gb1 polypeptide in the N-terminal of a protein to be expressed using pET28g backbone, using fusion sites 1 and 3
    Depositor
    Isabel Abreu
    Article
    Luis et al PLoS One. 2025 Jul 7;20(7):e0327341. doi
    Insert
    N-terminal tag with 8x His-residues in tandem with Gb1 polypeptide
    Expression
    Bacterial
    Available Since
    April 2, 2026
    Availability
    Academic Institutions and Nonprofits only
    249632-plasmid-map-sequence-id-504978

    Enlarge

  6. p028g13-MBP

    Plasmid
    #249631
    Purpose
    Clone MBP polypeptide in the N-terminal of a protein to be expressed using pET28g backbone, using fusion sites 1 and 3
    Depositor
    Isabel Abreu
    Article
    Luis et al PLoS One. 2025 Jul 7;20(7):e0327341. doi
    Insert
    N-terminal tag with MBP polypeptide
    Expression
    Bacterial
    Mutation
    Silent mutation on Gly-20 to remove a BsaI recogn…
    Available Since
    April 2, 2026
    Availability
    Academic Institutions and Nonprofits only
    249631-plasmid-map-sequence-id-504970

    Enlarge

  11. pACAGW-ChR2-Venus-AAV (AAV1)

    Viral Prep
    #20071-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pACAGW-ChR2-Venus-AAV (#20071). In addition to the viral particles, you will also receive purified pACAGW-ChR2-Venus-AAV plasmid DNA. CAG-driven, channelrhodopsin fused to Venus for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karel Svoboda
    Article
    Leopoldo et al Nature. 2009 Jan 18.
    Promoter
    CAGG
    Tags
    Venus
    Available Since
    Feb. 21, 2018
    Availability
    Academic Institutions and Nonprofits only

  12. pACAGW-ChR2-Venus-AAV (AAV9)

    Viral Prep
    #20071-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pACAGW-ChR2-Venus-AAV (#20071). In addition to the viral particles, you will also receive purified pACAGW-ChR2-Venus-AAV plasmid DNA. CAG-driven, channelrhodopsin fused to Venus for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karel Svoboda
    Article
    Leopoldo et al Nature. 2009 Jan 18.
    Promoter
    CAGG
    Tags
    Venus
    Available Since
    March 15, 2018
    Availability
    Academic Institutions and Nonprofits only

  13. Anti-Neuroligin-3 [IPI-mNLGN3.3] (Recombinant Antibody)

    Antibody
    #219625-rAb
    Purpose
    Anti-Neuroligin-3 (mouse) chimeric recombinant antibody with fused human variable and rabbit constant domains; specific for human and mouse NLGN3. Does not cross-react with other NLGNs.
    Depositor
    Institute for Protein Innovation (IPI)
    Article
    et al IPI
    Recommended Applications
    Flow Cytometry and Immunocytochemistry
    Reactivity
    Human and Mouse
    Source Species
    Rabbit
    Isotype
    IgG
    Trial Size
    Not available to purchase
    Available Since
    Feb. 19, 2026
    Availability
    Industry, Academic Institutions, and Nonprofits
    Immunocytochemistry image by Institute for Protein Innovation (IPI)

  14. pAAV-CamKIIa-ChrimsonR-mScarlet-KV2.1 (AAV9)

    Viral Prep
    #124651-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CamKIIa-ChrimsonR-mScarlet-KV2.1 (#124651). In addition to the viral particles, you will also receive purified pAAV-CamKIIa-ChrimsonR-mScarlet-KV2.1 plasmid DNA. CamKIIa-driven expression of ChrimsonR fused to mScarlet fluorophore and targeted to neuronal soma for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Christopher Harvey
    Article
    Chettih et al Nature. 2019 Mar 6. pii: 10.1038/s41586-
    Promoter
    CaMKII
    Tags
    mScarlet
    Available Since
    Aug. 27, 2019
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-CamKIIa-C1V1(t/t)-mScarlet-KV2.1 (AAV9)

    Viral Prep
    #124650-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CamKIIa-C1V1(t/t)-mScarlet-KV2.1 (#124650). In addition to the viral particles, you will also receive purified pAAV-CamKIIa-C1V1(t/t)-mScarlet-KV2.1 plasmid DNA. CamKIIa-driven expression of C1V1(t/t) fused to mScarlet fluorophore and targeted to neuronal soma for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Christopher Harvey
    Article
    Chettih et al Nature. 2019 Mar 6. pii: 10.1038/s41586-
    Promoter
    CaMKII
    Tags
    mScarlet
    Available Since
    Dec. 2, 2019
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-EF1a-4mtGCaMP6f-DIO (AAV1)

    Viral Prep
    #179529-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-4mtGCaMP6f-DIO (#179529). In addition to the viral particles, you will also receive purified pAAV-EF1a-4mtGCaMP6f-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GCaMP8f. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Maarten Kole
    Article
    Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:
    Promoter
    EF1a
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only

  17. paavCAG-post-mGRASP-2A-dTomato (AAV5)

    Viral Prep
    #34912-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from paavCAG-post-mGRASP-2A-dTomato (#34912). In addition to the viral particles, you will also receive purified paavCAG-post-mGRASP-2A-dTomato plasmid DNA. CAG-driven expression of post-synaptic mGRASP-2A-dTomato for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jinhyun Kim
    Article
    Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi
    Promoter
    CAG
    Tags
    dTomato
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. paavCAG-pre-mGRASP-mCerulean (AAV5)

    Viral Prep
    #34910-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from paavCAG-pre-mGRASP-mCerulean (#34910). In addition to the viral particles, you will also receive purified paavCAG-pre-mGRASP-mCerulean plasmid DNA. CAG-driven expression of presynaptic mGRASP-mCerulean for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jinhyun Kim
    Article
    Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi
    Promoter
    CAG
    Tags
    mCerulean
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-CamKIIa-ChrimsonR-mScarlet-KV2.1 (AAV1)

    Viral Prep
    #124651-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CamKIIa-ChrimsonR-mScarlet-KV2.1 (#124651). In addition to the viral particles, you will also receive purified pAAV-CamKIIa-ChrimsonR-mScarlet-KV2.1 plasmid DNA. CamKIIa-driven expression of ChrimsonR fused to mScarlet fluorophore and targeted to neuronal soma for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Christopher Harvey
    Article
    Chettih et al Nature. 2019 Mar 6. pii: 10.1038/s41586-
    Promoter
    CaMKII
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-EF1a-mitoGFP-DIO (AAV2)

    Viral Prep
    #174112-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-EF1a-mitoGFP-DIO (#174112). In addition to the viral particles, you will also receive purified pAAV-EF1a-mitoGFP-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Maarten Kole
    Article
    Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:
    Promoter
    EF1a
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 4561 - 4580 of 15622 results